NCT04067830
- Conditions
- Lung Diseases, Lung Neoplasms, Neoplasms, +14 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
Clinical trial condition
Stage IIIB Lung Cancer AJCC v8
Explore clinical trials studying Stage IIIB Lung Cancer AJCC v8. Study availability and eligibility vary by location and protocol.
58 public trials
14 recruiting studies
Stage IIIB Lung Cancer AJCC v8 trial results
NCT07288034
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- CTCA at Western Regional Medical Center Goodyear, Arizona, United States
- City of Hope Corona Corona, California, United States
- City of Hope Medical Center Duarte, California, United States
- City of Hope Seacliff Huntington Beach, California, United States
NCT03948100
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +31 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT06918132
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Active, not recruiting
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
NCT02194738
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +14 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Southern Cancer Center PC-Daphne Daphne, Alabama, United States
- Southern Cancer Center PC-Mobile Mobile, Alabama, United States
- Southern Cancer Center PC-Providence Mobile, Alabama, United States
Active, not recruiting
Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy
NCT03965689
- Conditions
- Lung Diseases, Lung Neoplasms, Metastatic Lung Non-Small Cell Squamous Carcinoma, +12 more
- Locations
-
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- USC Norris Oncology/Hematology-Newport Beach Newport Beach, California, United States
- MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
Active, not recruiting
Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer
NCT03793179
- Conditions
- Lung Diseases, Lung Neoplasms, Lung Non-Squamous Non-Small Cell Carcinoma, +8 more
- Locations
-
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
Active, not recruiting
Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer
NCT06732401
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
- Tower Cancer Research Foundation Beverly Hills, California, United States
- Cedars-Sinai Medical Center Los Angeles, California, United States
- Cedars-Sinai Cancer - Tarzana Tarzana, California, United States
Active, not recruiting
Osimertinib, Surgery, and Radiation Therapy in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer With EGFR Mutations, NORTHSTAR Study
NCT03410043
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
- Locations
-
- UCSF Medical Center-Mount Zion San Francisco, California, United States
- University of Colorado Denver, Colorado, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- M D Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma
NCT04940299
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +72 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States